GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quotient Ltd (OTCPK:QTNTQ) » Definitions » 5-Day RSI

Quotient (Quotient) 5-Day RSI : 49.69 (As of May. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Quotient 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2024-05-04), Quotient's 5-Day RSI is 49.69.

The industry rank for Quotient's 5-Day RSI or its related term are showing as below:

QTNTQ's 5-Day RSI is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 55.515 vs QTNTQ: 49.69

Competitive Comparison of Quotient's 5-Day RSI

For the Medical Devices subindustry, Quotient's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quotient's 5-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Quotient's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Quotient's 5-Day RSI falls into.



Quotient  (OTCPK:QTNTQ) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quotient  (OTCPK:QTNTQ) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Quotient 5-Day RSI Related Terms

Thank you for viewing the detailed overview of Quotient's 5-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Quotient (Quotient) Business Description

Traded in Other Exchanges
N/A
Address
Business Park Terre Bonne, Route de Crassier 13, Eysins, CHE, 1262
Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.
Executives
Highbridge Capital Management Llc 10 percent owner 277 PARK AVE, 23RD FLOOR, NEW YORK NY 10172
Quotient Holdings Finance Co Ltd 10 percent owner C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, 71 FORT STREET, PO BOX 500, GRAND CAYMAN E9 KY1-1106
Quotient Holdings Newco, Lp 10 percent owner C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON DE 19801
Quotient Holdings Merger Co Ltd 10 percent owner PO BOX 536, 13-14 ESPLANADE, ST. HELIER Y9 JE4 5UR
Quotient Holdings Gp, Llc 10 percent owner C/O THE CORPORATION TRUST COMPANY, 1209 ORANGE STREET, WILMINGTON DE 19801
Isabelle Buckle director C/O QUOTIENT LIMITED, B1, BUSINESS PARK, TERRE BONNE, ROUTE DE CRASSIER 13, EYSINS V8 1262
Prondzynski Heino Von director 275 NORTH FIELD DRIVE, LAKE FOREST IL 60045
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Sophie Bechu director C/O QUOTIENT LIMITED, BUSINESS PARK TERRE BONNE, EYSINS V8 1262
Frederick Hallsworth director THE GARDEN WING, HOUSTON HOUSE, KIRK ROAD, HOUSTON X0 PA6 7AR
Manuel O. Mendez director, officer: Chief Executive Officer 500 PLAZA DRIVE, SECAUCUS NJ 07094
L John Wilkerson director, 10 percent owner C/O GALEN ASSOCIATES, 610 FIFTH AVENUE 5TH FLOOR, NEW YORK NY 10020
Zubeen Shroff director, 10 percent owner C/O HALSEY DRUG CO INC, 1827 PACIFIC STREET, BROOKLYN NY 11233
Ali Kiboro officer: Chief Financial Officer C/O QUOTIENT LIMITED, B1, BUSINESS PARK TERRE BONNE, EYSINS V8 1262
Brian Mcdonough director 12521 MARET DRIVE, ST. LOUIS MO 63127